Back
Also listed as
AXAHF
OTC
Day Range
$43.85
$44.82
52-Week Range
$38.21
$50.95
Volume
25,747
50D / 200D Avg
$45.71
/
$46.77
Prev Close
$43.49
Price History
Financial Trends
Peer Comparison
vs Financial Services sector median (854 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 9.9 | 10.3 |
| P/B | 2.0 | 1.1 |
| ROE % | 19.4 | 11.7 |
| Net Margin % | 8.5 | 16.8 |
| Rev Growth 5Y % | -0.2 | 11.7 |
| D/E | 0.3 | 0.5 |
Key Takeaways
Revenue declined -0.16% annually over 5 years
Earnings grew 19.33% over the past year
ROE of 19.38% — decent returns on equity
Debt/Equity of 0.33 — conservative balance sheet
Generating 11.99B in free cash flow
P/E of 9.87 — trading at a low valuation
Growth
Revenue Growth (5Y)
-0.16%
Revenue (1Y)23.54%
Earnings (1Y)19.33%
FCF Growth (3Y)26.21%
Quality
Return on Equity
19.38%
ROIC0.00%
Net Margin8.48%
Op. Margin0.00%
Safety
Debt / Equity
0.33
Current RatioN/A
Interest Coverage0.00
Valuation
P/E Ratio
9.87
P/B Ratio1.97
EV/EBITDAN/A
Dividend Yield0.05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 23.54% | Revenue Growth (3Y) | 12.84% |
| Earnings Growth (1Y) | 19.33% | Earnings Growth (3Y) | 14.41% |
| Revenue Growth (5Y) | -0.16% | Earnings Growth (5Y) | 6.58% |
| Profitability | |||
| Revenue (TTM) | 110.96B | Net Income (TTM) | 9.41B |
| ROE | 19.38% | ROA | 1.48% |
| Gross Margin | 100.00% | Operating Margin | 0.00% |
| Net Margin | 8.48% | Free Cash Flow (TTM) | 11.99B |
| ROIC | 0.00% | FCF Growth (3Y) | 26.21% |
| Safety | |||
| Debt / Equity | 0.33 | Current Ratio | N/A |
| Interest Coverage | 0.00 | Dividend Yield | 0.05% |
| Valuation | |||
| P/E Ratio | 9.87 | P/B Ratio | 1.97 |
| P/S Ratio | 0.84 | PEG Ratio | 0.27 |
| EV/EBITDA | N/A | Dividend Yield | 0.05% |
| Market Cap | 92.91B | Enterprise Value | 86.51B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 110.96B | 89.82B | 87.15B | 86.79B | 111.69B |
| Net Income | 9.41B | 7.89B | 7.19B | 5.06B | 7.29B |
| EPS (Diluted) | 4.50 | 3.47 | 3.13 | 2.12 | 2.97 |
| Gross Profit | 110.96B | 89.82B | 87.15B | 86.79B | 99.03B |
| Operating Income | 0.0 | 9.98B | 9.22B | 7.38B | 9.66B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 635.23B | 653.76B | 644.45B | 696.70B | 775.49B |
| Total Liabilities | 585.75B | 601.28B | 597.49B | 648.32B | 700.26B |
| Shareholders' Equity | 47.18B | 49.94B | 49.58B | 46.07B | 71.13B |
| Total Debt | 15.79B | 62.14B | 59.54B | 63.75B | 61.84B |
| Cash & Equivalents | 22.19B | 18.99B | 25.38B | 26.17B | 25.05B |
| Current Assets | 46.08B | 9.90B | 320.12B | 323.68B | 424.91B |
| Current Liabilities | 0.0 | 0.0 | 45.85B | 1.89B | 26.56B |
Strategy Scores
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026
Entered
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026